Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Baker

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
Clinical Epidemiology|December 12, 2023
Health Inequality in Eight Adverse Outcomes Over a 25-Year Period in a Multi-Ethnic Population in New Zealand Population with Impaired Glucose Tolerance and/or Impaired Fasting Glucose: An Age-Period-Cohort AnalysisZheng Wang, Dahai Yu, Uchechukwu Levi Osuagwu, et al.
Diabetes Care|August 7, 2021
Metabolic Profiles of Maori, Pacific, and European New Zealanders With Type 2 Diabetes Over 25 YearsDahai Yu, Yamei Cai, Uchechukwu Levi Osuagwu, et al.
Diabetes Research and Clinical Practice|May 10, 2022
Ethnic differences in metabolic achievement between Māori, Pacific, and European New Zealanders with type 2 diabetesDahai Yu, Yamei Cai, Uchechukwu Levi Osuagwu, et al.
Critical Pathways in Cardiology|February 19, 2021
Impact of Age in Acute Myocardial Infarction Cardiogenic Shock: Insights From the National Cardiogenic Shock InitiativeAlejandro Lemor, Mir B Basir, Sarah Gorgis, et al.
BMJ Open Diabetes Research & Care|December 4, 2024
Comparative risk of type 2 diabetes development between women with gestational diabetes and women with impaired glucose tolerance over two decades: a multiethnic prospective cohort in New ZealandDahai Yu, Hang Fu, Zhanzheng Zhao, et al.
BMC Medicine|November 10, 2024
Association between within-target risk factors and life expectancy free from cardiovascular disease, cancer, and dementia in individuals with type 2 diabetes in New Zealand between 1994 and 2018: a multi-ethnic cohort studyDahai Yu, Zhanzheng Zhao, Karen Pickering, et al.
Cardiovascular Diabetology|June 30, 2023
Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysisDahai Yu, Bingjie Qu, Uchechukwu Levi Osuagwu, et al.
BMC Cancer|July 25, 2024
Cancer risk following onset of type 2 diabetes in New Zealanders with impaired glucose tolerance over 25 years: a matched prospective cohort studyZheng Wang, Dahai Yu, Uchechukwu Levi Osuagwu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2024
Long-term impact of type 2 diabetes onset on dementia incidence rate among New Zealanders with impaired glucose tolerance: A tapered-matched landmark analysis over 25 yearsDahai Yu, Zheng Wang, Uchechukwu Levi Osuagwu, et al.
BMJ Open Diabetes Research & Care|December 15, 2022
Ethnic differences in 25-year risk of incident chronic kidney disease among people with type 2 diabetes in New ZealandDahai Yu, Zheng Wang, Yamei Cai, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Clinical Epidemiology|December 12, 2023
Health Inequality in Eight Adverse Outcomes Over a 25-Year Period in a Multi-Ethnic Population in New Zealand Population with Impaired Glucose Tolerance and/or Impaired Fasting Glucose: An Age-Period-Cohort AnalysisZheng Wang, Dahai Yu, Uchechukwu Levi Osuagwu, et al.
Diabetes Care|August 7, 2021
Metabolic Profiles of Maori, Pacific, and European New Zealanders With Type 2 Diabetes Over 25 YearsDahai Yu, Yamei Cai, Uchechukwu Levi Osuagwu, et al.
Diabetes Research and Clinical Practice|May 10, 2022
Ethnic differences in metabolic achievement between Māori, Pacific, and European New Zealanders with type 2 diabetesDahai Yu, Yamei Cai, Uchechukwu Levi Osuagwu, et al.
Critical Pathways in Cardiology|February 19, 2021
Impact of Age in Acute Myocardial Infarction Cardiogenic Shock: Insights From the National Cardiogenic Shock InitiativeAlejandro Lemor, Mir B Basir, Sarah Gorgis, et al.
BMJ Open Diabetes Research & Care|December 4, 2024
Comparative risk of type 2 diabetes development between women with gestational diabetes and women with impaired glucose tolerance over two decades: a multiethnic prospective cohort in New ZealandDahai Yu, Hang Fu, Zhanzheng Zhao, et al.
BMC Medicine|November 10, 2024
Association between within-target risk factors and life expectancy free from cardiovascular disease, cancer, and dementia in individuals with type 2 diabetes in New Zealand between 1994 and 2018: a multi-ethnic cohort studyDahai Yu, Zhanzheng Zhao, Karen Pickering, et al.
Cardiovascular Diabetology|June 30, 2023
Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysisDahai Yu, Bingjie Qu, Uchechukwu Levi Osuagwu, et al.
BMC Cancer|July 25, 2024
Cancer risk following onset of type 2 diabetes in New Zealanders with impaired glucose tolerance over 25 years: a matched prospective cohort studyZheng Wang, Dahai Yu, Uchechukwu Levi Osuagwu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2024
Long-term impact of type 2 diabetes onset on dementia incidence rate among New Zealanders with impaired glucose tolerance: A tapered-matched landmark analysis over 25 yearsDahai Yu, Zheng Wang, Uchechukwu Levi Osuagwu, et al.
BMJ Open Diabetes Research & Care|December 15, 2022
Ethnic differences in 25-year risk of incident chronic kidney disease among people with type 2 diabetes in New ZealandDahai Yu, Zheng Wang, Yamei Cai, et al.
Pageof 21